vs
Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Claritev Corp (CTEV). Click either name above to swap in a different company.
CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $246.6M, roughly 2.0× Claritev Corp). CLOVER HEALTH INVESTMENTS, CORP. runs the higher net margin — -10.1% vs -32.7%, a 22.6% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 6.2%). Claritev Corp produced more free cash flow last quarter ($36.4M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 2.5%).
Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.
CLOV vs CTEV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $487.7M | $246.6M |
| Net Profit | $-49.3M | $-80.6M |
| Gross Margin | — | — |
| Operating Margin | -10.1% | -3.1% |
| Net Margin | -10.1% | -32.7% |
| Revenue YoY | 44.7% | 6.2% |
| Net Profit YoY | -123.2% | 41.6% |
| EPS (diluted) | — | $-4.88 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $487.7M | $246.6M | ||
| Q3 25 | $496.6M | $246.0M | ||
| Q2 25 | $477.6M | $241.6M | ||
| Q1 25 | $462.3M | $231.3M | ||
| Q4 24 | $337.0M | $232.1M | ||
| Q3 24 | $331.0M | $230.5M | ||
| Q2 24 | $356.3M | $233.5M | ||
| Q1 24 | $346.9M | $234.5M |
| Q4 25 | $-49.3M | $-80.6M | ||
| Q3 25 | $-24.4M | $-69.8M | ||
| Q2 25 | $-10.6M | $-62.6M | ||
| Q1 25 | $-1.3M | $-71.3M | ||
| Q4 24 | $-22.1M | $-138.0M | ||
| Q3 24 | $-9.2M | $-391.4M | ||
| Q2 24 | $7.4M | $-576.7M | ||
| Q1 24 | $-19.2M | $-539.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 24.5% | — | ||
| Q2 24 | 30.3% | — | ||
| Q1 24 | 23.6% | — |
| Q4 25 | -10.1% | -3.1% | ||
| Q3 25 | -4.9% | 4.1% | ||
| Q2 25 | -2.2% | 6.9% | ||
| Q1 25 | -0.3% | 4.2% | ||
| Q4 24 | -6.4% | -17.8% | ||
| Q3 24 | -2.7% | -146.7% | ||
| Q2 24 | 2.0% | -224.4% | ||
| Q1 24 | -6.5% | -207.4% |
| Q4 25 | -10.1% | -32.7% | ||
| Q3 25 | -4.9% | -28.4% | ||
| Q2 25 | -2.2% | -25.9% | ||
| Q1 25 | -0.3% | -30.8% | ||
| Q4 24 | -6.6% | -59.4% | ||
| Q3 24 | -2.8% | -169.8% | ||
| Q2 24 | 2.1% | -247.0% | ||
| Q1 24 | -5.5% | -230.1% |
| Q4 25 | — | $-4.88 | ||
| Q3 25 | — | $-4.23 | ||
| Q2 25 | — | $-3.81 | ||
| Q1 25 | — | $-4.38 | ||
| Q4 24 | — | $-8.49 | ||
| Q3 24 | — | $-24.25 | ||
| Q2 24 | — | $-35.78 | ||
| Q1 24 | — | $-33.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $78.3M | $16.8M |
| Total DebtLower is stronger | — | $4.6B |
| Stockholders' EquityBook value | $308.7M | $-173.9M |
| Total Assets | $541.0M | $4.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $78.3M | $16.8M | ||
| Q3 25 | — | $39.2M | ||
| Q2 25 | — | $56.4M | ||
| Q1 25 | — | $23.1M | ||
| Q4 24 | $194.5M | $16.8M | ||
| Q3 24 | $288.0M | $86.6M | ||
| Q2 24 | $254.8M | $48.8M | ||
| Q1 24 | $208.3M | $58.7M |
| Q4 25 | — | $4.6B | ||
| Q3 25 | — | $4.5B | ||
| Q2 25 | — | $4.5B | ||
| Q1 25 | — | $4.5B | ||
| Q4 24 | — | $4.5B | ||
| Q3 24 | — | $4.5B | ||
| Q2 24 | — | $4.5B | ||
| Q1 24 | — | $4.5B |
| Q4 25 | $308.7M | $-173.9M | ||
| Q3 25 | $340.9M | $-101.8M | ||
| Q2 25 | $344.2M | $-39.9M | ||
| Q1 25 | $336.1M | $14.8M | ||
| Q4 24 | $341.1M | $84.0M | ||
| Q3 24 | $342.2M | $207.6M | ||
| Q2 24 | $324.9M | $603.4M | ||
| Q1 24 | $292.5M | $1.2B |
| Q4 25 | $541.0M | $4.9B | ||
| Q3 25 | $559.7M | $5.0B | ||
| Q2 25 | $575.0M | $5.1B | ||
| Q1 25 | $583.7M | $5.1B | ||
| Q4 24 | $580.7M | $5.2B | ||
| Q3 24 | $653.0M | $5.3B | ||
| Q2 24 | $674.2M | $5.7B | ||
| Q1 24 | $671.8M | $6.4B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 304.87× | ||
| Q4 24 | — | 53.67× | ||
| Q3 24 | — | 21.73× | ||
| Q2 24 | — | 7.48× | ||
| Q1 24 | — | 3.85× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-66.9M | $66.3M |
| Free Cash FlowOCF − Capex | $-69.0M | $36.4M |
| FCF MarginFCF / Revenue | -14.1% | 14.8% |
| Capex IntensityCapex / Revenue | 0.4% | 12.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-69.2M | $-12.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-66.9M | $66.3M | ||
| Q3 25 | $12.1M | $19.9M | ||
| Q2 25 | $5.4M | $61.2M | ||
| Q1 25 | $-16.3M | $-30.1M | ||
| Q4 24 | $34.8M | $-33.4M | ||
| Q3 24 | $50.0M | $72.8M | ||
| Q2 24 | $44.8M | $18.5M | ||
| Q1 24 | $25.9M | $49.7M |
| Q4 25 | $-69.0M | $36.4M | ||
| Q3 25 | $11.4M | $-16.3M | ||
| Q2 25 | $4.8M | $36.6M | ||
| Q1 25 | $-16.5M | $-68.9M | ||
| Q4 24 | $33.3M | $-63.8M | ||
| Q3 24 | $49.6M | $41.1M | ||
| Q2 24 | $44.4M | $-7.0M | ||
| Q1 24 | $25.5M | $19.2M |
| Q4 25 | -14.1% | 14.8% | ||
| Q3 25 | 2.3% | -6.6% | ||
| Q2 25 | 1.0% | 15.2% | ||
| Q1 25 | -3.6% | -29.8% | ||
| Q4 24 | 9.9% | -27.5% | ||
| Q3 24 | 15.0% | 17.8% | ||
| Q2 24 | 12.5% | -3.0% | ||
| Q1 24 | 7.3% | 8.2% |
| Q4 25 | 0.4% | 12.1% | ||
| Q3 25 | 0.1% | 14.7% | ||
| Q2 25 | 0.1% | 10.2% | ||
| Q1 25 | 0.0% | 16.8% | ||
| Q4 24 | 0.5% | 13.1% | ||
| Q3 24 | 0.1% | 13.8% | ||
| Q2 24 | 0.1% | 10.9% | ||
| Q1 24 | 0.1% | 13.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 6.04× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.